the aid library

LIST OPTIONS

Filter

609

Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map

Van Katwyk, S. R.; Grimshaw, J. M.; et al (2019) C2

BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc...e map can support governments in making evidence-informed decisions about implementing programs to reduce AMR, by identifying, describing, and assessing the full range of evaluated government policy options to reduce antimicrobial use in humans. METHODS AND FINDINGS: Seven databases were searched from inception to January 28, 2019, (MEDLINE, CINAHL, EMBASE, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science, and PubMed). We identified studies that (1) clearly described a government policy intervention aimed at reducing human antimicrobial use, and (2) applied a quantitative design to measure the impact. We found 69 unique evaluations of government policy interventions carried out across 4 of the 6 WHO regions. These evaluations included randomized controlled trials (n = 4), non-randomized controlled trials (n = 3), controlled before-and-after designs (n = 7), interrupted time series designs (n = 25), uncontrolled before-and-after designs (n = 18), descriptive designs (n = 10), and cohort designs (n = 2). From these we identified 17 unique policy options for governments to reduce the human use of antimicrobials. Many studies evaluated public awareness campaigns (n = 17) and antimicrobial guidelines (n = 13); however, others offered different policy options such as professional regulation, restricted reimbursement, pay for performance, and prescription requirements. Identifying these policies can inform the development of future policies and evaluations in different contexts and health systems. Limitations of our study include the possible omission of unpublished initiatives, and that policies not evaluated with respect to antimicrobial use have not been captured in this review. CONCLUSIONS: To our knowledge this is the first study to provide policy makers with synthesized evidence on specific government policy interventions addressing AMR. In the future, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published. more

External Link

Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries

Hsia Y., B. R Lee, A. Versporten, et al The Lancet (2019) C2

Improving the quality of hospital antibiotic use is a major goal of WHO’s global action plan to combat antimicrobial resistance. The WHO Essential Medicines List Access, Watch, and Reserve (AWaRe) classification could facilitate simple stewardship interventions that are widely applicable globally.... more

Download (538)

View PDF (777)

The 2014 Hepatology Society of the Philippines Consensus Statements on the Diagnosis and Treatment of Hepatitis C

Stephen N. Wong, Jane R. Campos, Ian Homer Y. Cua et al. Hepatology Society of the Philippines (HSP) (2006) C1

External Link

mHealth intervention “ImTeCHO” to improve delivery of maternal, neonatal, and child care services—A cluster-randomized trial in tribal areas of Gujarat, India

Modi, D., N. Dholakia, R. Gopalan, et al. (2019) CC

Download (86)

View PDF (189)

Air pollution exposure—the (in)visible risk factor for respiratory diseases

Bălă, G.P.; Râjnoveanu, R.M.; Tudorache, E. et al. Environmental Science and Pollution Research (2021) CC

There is increasing interest in understanding the role of air pollution as one of the greatest threats to human health worldwide. Nine of 10 individuals breathe air with polluted compounds that have a great impact on lung tissue. The nature of the relationship is complex, and new or updated data are... more

Download (473)

View PDF (435)

COVID Reference 2021.6 EN
recommended

Kamps, B.S.; Camp, R. and C. Hoffmann (2021) CC

External Link

Medication adherence to antiretroviral therapy among newly treated people living with HIV

Y. Yu; D. Luo; X. Chen; et al. BMC Public Health (2018) CC

Yu et al. BMC Public Health (2018) 18:825 https://doi.org/10.1186/s12889-018-5731-z Research Article

External Link

A Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta- Analysis

M. G. Whitfield, H. M. Soeters, R. M. Warren, et al. PLOS One; I. Mokrousov, (St. Petersburg Pasteur Institute) (2015) CC

PLOS ONE | DOI:10.1371/journal.pone.0133869 July 28, 2015, p.1-16

External Link

Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand
recommended

Neil M Ferguson, Daniel Laydon, Gemma Nedjati-Gilani, Natsuko Imai, Kylie Ainslie, Marc Baguelin, Sangeeta Bhatia, Adhiratha Boonyasiri, Zulma Cucunubá, Gina Cuomo-Dannenburg, Amy Dighe, Ilaria Dorigatti, Han Fu, Katy Gaythorpe, Will Green, Arran Hamlet, Wes Hinsley, Lucy C Okell, Sabine van Elsland, Hayley Thompson, Robert Verity, Erik Volz, Haowei Wang, Yuanrong Wang, Patrick GT Walker, Caroline Walters, Peter Winskill, Charles Whittaker, Christl A Donnelly, Steven Riley, Azra C Ghani. Imperial College COVID-19 Response Team (2020) C1

The global impact of COVID-19 has been profound, and the public health threat it represents is the most serious seen in a respiratory virus since the 1918 H1N1 influenza pandemic. Here we present the results of epidemiological modelling which has informed policymaking in the UK and other countries i... more

Download (115)

View PDF (201)

2020 Brazilian Thoracic Association recommendations for the management of asthma

Menezes Pizzichini, M. M.; de Carvalho-Pinto, R. M.; Delfini Cançado, J. E.; et al. (2020) CC2

The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal of asthma treatment should be to achieve and maintain control of the... more

Download (94)

View PDF (172)

Recomendações para o manejo da asma da Sociedade Brasileira de Pneumologia e Tisiologia – 2020

Menezes Pizzichini, M. M.; de Carvalho-Pinto, R. M.; Delfini Cançado, J. E.; et al. (2020) CC2

Download (76)

View PDF (74)

Silica-associated lung disease: An old-world exposure in modern industries

Barnes, H.; Goh, N. S. L.; Leong, T. L.; Hoy, R. Official Journal of the Asian Pacific Society of Respirology (2019) CC2

Silicosis is not a new disease; the impact of silica dust on respiratory function was observed by Hippocrates in 430 B.C. and in the 16th century by Agricol. In 1713, Rammazini described silicotic nodules in post-mortems of stone cutters presenting with respiratory symptoms. In the mid-late 1800s,... more

Download (190)

View PDF (286)

Headache disorders and public ill-health in India: prevalence estimates in Karnataka State

G. B Kulkarni; G. N. Rao; G. Gururaj; et al. The Journal of Headache and Pain; BMC (2015) CC

Kulkarni et al. The Journal of Headache and Pain (2015) 16:67 DOI 10.1186/s10194-015-0549-x

Download (141)

View PDF (166)

Expanding our understanding of post COVID-19 condition: report of a WHO webinar

World Health Organization WHO (2021) C_WHO

On 9 February 2021, a first webinar entitled “Expanding our understanding of Post COVID-19 condition” was held under the auspices of WHO and in consultation with the International Severe Acute Respiratory and Emerging Infection Consortium(ISARIC), Global Research Collaboration for Infectious Dis... more

External Link

Drug-resistant tuberculosis in Central Mozambique: the role of a rapid genotypic susceptibility testing

Evangelina IN, Inês T, Miguelhete L et al (2016) CC

This study consists of a descriptive analysis of M. tuberculosis isolates from Beira Central Hospital, Mozambique, during 2014–2015, being the first report of a genotypic testing used to provide information about second line drug resistance in Mozambique. BMC Infectious Diseases (2016) 16:423 DO... more

Download (109)

View PDF (152)

Position Statement on transmission of SARS-CoV-2 by pre-asymptomatic and asymptomatic individuals - Arabic version

African Union; Africa CDC Centres for Disease Control and Prevention (2020) C1

ل المتلازمة التنفسية الحادة ٢خطر انتقال فيروس كورونا المستجدعلى مدى الأسابيع الماضية، كان هناك اهتمام واسع من جانب وسائل الإعلام حو [فيروس السارس ) من قبل الأفراد ع... more

External Link

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

Greinacher, A., et al. (2021) CC

New England Journal of Medicine April 9, 2021 DOI: 10.1056/NEJMoa2104840

External Link

Stark choices: exploring health sector costs of policy responses to COVID-19 in low-income and middle-income countries

Torres-Rueda S.; S. Sweeney; F. Bozzani et al. BMJ Global Health (2021) C2

COVID-19 has altered health sector capacity in low-income and middle-income countries (LMICs). Cost data to inform evidence-based priority setting are urgently needed. Consequently, in this paper, we calculate the full economic health sector costs of COVID-19 clinical management in 79 LMICs under di... more

External Link

A global inventory of small floating plastic debris

van Sebille, E.; C. Wilcox, L. Lebreton et al. IOP Science (2015) CC

Environmental Research Letters Microplastic debris floating at the ocean surface can harm marine life. Understanding the severity of this harm requires knowledge of plastic abundance and distributions. Dozens of expeditions measuring microplastics have been carried out since the 1970s, but they ha... more

Download (316)

View PDF (468)

шахтеры (Miners -Russian edition)

FG Consulting Group; D. Daniels, C. Smyth, et al. Stop TB Partnership; UNOPS; END TB (2016) C1

В этом разделе рассматривается недостаток доступа к медицинской помощи и непрерывности ее оказания внутри и вокруг мест добычи, а также политики, которые препятст... more

COVID Reference 2021.6 EN recommended

Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand recommended

COVID Reference 2021.6 EN
recommended

Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand
recommended